Advertisements


We are Sorry, This Page doesn't Exist


Biotech Analysis Central Pharma News: Cytodyn"s Acquisition, Novartis Exits Antibotic Research, Advaxis" FDA Hold Removed

Biotech Analysis Central Pharma News: Cytodyn"s Acquisition, Novartis Exits Antibotic Research, Advaxis" FDA Hold Removed.....»»

Category: topSource: seekingalphaJul 15th, 2018

Biotech Analysis Central Pharma News: Pfizer"s Unit Separation, BioCryst"s Merger Collapses, Scynexis" Positive Mid-Stage Results

Biotech Analysis Central Pharma News: Pfizer"s Unit Separation, BioCryst"s Merger Collapses, Scynexis" Positive Mid-Stage Results.....»»

Category: topSource: seekingalphaJul 12th, 2018

Biotech Analysis Central Pharma News: Catabasis Nears Phase 3 Start, Regulus Slashes Workforce, Cytori"s Mixed ED Data

Biotech Analysis Central Pharma News: Catabasis Nears Phase 3 Start, Regulus Slashes Workforce, Cytori"s Mixed ED Data.....»»

Category: topSource: seekingalphaJul 10th, 2018

Biotech Analysis Central Pharma News: Puma"s Reversal Win, Pain Therapeutics Suffers Major Blow, Achaogen"s FDA Score

Biotech Analysis Central Pharma News: Puma"s Reversal Win, Pain Therapeutics Suffers Major Blow, Achaogen"s FDA Score.....»»

Category: topSource: seekingalphaJun 27th, 2018

Biotech Analysis Central Pharma News: Takeda"s Acquisition Win, Ionis And Akcea Tumble, Alnylam"s Advance In CNS

Biotech Analysis Central Pharma News: Takeda"s Acquisition Win, Ionis And Akcea Tumble, Alnylam"s Advance In CNS.....»»

Category: topSource: seekingalphaMay 9th, 2018

Biotech Analysis Central Pharma News: Synthetic Loses Designation, Sage Files NDA , Alnylam Gets Positive Opinion From EMA

Biotech Analysis Central Pharma News: Synthetic Loses Designation, Sage Files NDA , Alnylam Gets Positive Opinion From EMA.....»»

Category: topSource: seekingalphaApr 24th, 2018

Biotech Analysis Central Pharma News: Allergan And Richter"s Success, Sellas Life Sciences" Breast Cancer Data, AbbVie"s Patent Boost

Biotech Analysis Central Pharma News: Allergan And Richter"s Success, Sellas Life Sciences" Breast Cancer Data, AbbVie"s Patent Boost.....»»

Category: topSource: seekingalphaApr 9th, 2018

Biotech Analysis Central Pharma News: Zogenix"s Late-Stage Win, Zynerba"s Bounce Back, Abbvie"s Expanded Venetoclax Use

Biotech Analysis Central Pharma News: Zogenix"s Late-Stage Win, Zynerba"s Bounce Back, Abbvie"s Expanded Venetoclax Use.....»»

Category: topSource: seekingalphaJul 16th, 2018

Biotech Analysis Central Pharma News: CytoDyn"s BLA Update, Anika"s Failure, Vertex"s Expansion Of Facility

Biotech Analysis Central Pharma News: CytoDyn"s BLA Update, Anika"s Failure, Vertex"s Expansion Of Facility.....»»

Category: topSource: seekingalphaJun 25th, 2018

Biotech Analysis Central Pharma News: Roche Abandons Drug, Gilead"s Early Stage Bet, Vaxart"s Phase 2 Failure

Biotech Analysis Central Pharma News: Roche Abandons Drug, Gilead"s Early Stage Bet, Vaxart"s Phase 2 Failure.....»»

Category: topSource: seekingalphaJun 6th, 2018

Biotech Analysis Central Pharma News: Takeda Raises Shire Bid, Daiichi Fails DMD Trial, Celldex Cuts 20% Of Workforce

Biotech Analysis Central Pharma News: Takeda Raises Shire Bid, Daiichi Fails DMD Trial, Celldex Cuts 20% Of Workforce.....»»

Category: topSource: seekingalphaApr 26th, 2018

Biotech Analysis Central Pharma News: Orexigen"s Last Resort, Epizyme"s Partial Clinical Hold, Eli Lilly And Incyte"s Mixed Advisory Panel Vote

Biotech Analysis Central Pharma News: Orexigen"s Last Resort, Epizyme"s Partial Clinical Hold, Eli Lilly And Incyte"s Mixed Advisory Panel Vote.....»»

Category: topSource: seekingalphaApr 24th, 2018

Biotech Analysis Central Pharma News: Biogen"s Deal, Eli Lilly Partner Incyte Refile Baricitinib, Argos Loses Out

Biotech Analysis Central Pharma News: Biogen"s Deal, Eli Lilly Partner Incyte Refile Baricitinib, Argos Loses Out.....»»

Category: topSource: seekingalphaApr 23rd, 2018

Biotech Analysis Central Pharma News: J&J Scraps Antibiotic Program, Novartis Siponimod, GW Pharma"s Major Support By Panel

Biotech Analysis Central Pharma News: J&J Scraps Antibiotic Program, Novartis Siponimod, GW Pharma"s Major Support By Panel.....»»

Category: topSource: seekingalphaApr 23rd, 2018

Biotech Analysis Central Pharma News: Merck"s Keytruda Breakthrough, Bristol Myers And JNJ Team Up, Alkermes Gets A Second Shot

Biotech Analysis Central Pharma News: Merck"s Keytruda Breakthrough, Bristol Myers And JNJ Team Up, Alkermes Gets A Second Shot.....»»

Category: topSource: seekingalphaApr 17th, 2018

Biotech Analysis Central Pharma News: GlaxoSmithKline Passes Along Pipeline, Pulse Impresses, Celldex"s Failure

Biotech Analysis Central Pharma News: GlaxoSmithKline Passes Along Pipeline, Pulse Impresses, Celldex"s Failure.....»»

Category: topSource: seekingalphaApr 17th, 2018

Biotech Analysis Central Pharma News: Novartis"s Gene Therapy Catch, AstraZeneca"s NASH Move, Clovis"s Expanded Rubraca Market

Biotech Analysis Central Pharma News: Novartis"s Gene Therapy Catch, AstraZeneca"s NASH Move, Clovis"s Expanded Rubraca Market.....»»

Category: topSource: seekingalphaApr 11th, 2018

4 Biotech Bets to Watch as Industry Rebounds in a Month

The biotech sector makes a sharp rise in 30 days post the positive data read out from Biogen's mid-stage Alzheimer's trial on BAN2401. We recommend a few industry playe.....»»

Category: personnelSource: nyt6 hr. 23 min. ago

UPDATE: Cara Therapeutics stock surges 34% on news of positive results in trial of post-surgery pain treatment

Cara Therapeutics Inc. shares soared 34% in premarket trade Wednesday, after the company reported positive data in a Phase 2/3 trial of a t.....»»

Category: topSource: marketwatchJun 27th, 2018

Cara Therapeutics reports positive data in midstage trial of post-surgery pain treatment

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJun 27th, 2018